Joe Biden beats President Donald Trump in three polls released last week. What was surprising is that Biden was able to pull off the feat despite the recent resurgence in Trump’s popularity as his administration confronts the coronavirus outbreak in the U.S.
Joe Biden posted a two-point lead over Donald Trump in an ABC News/Washington Post poll. Biden got 49 percent over Trump’s 47 percent based on results released on Sunday, according to Politico.
Biden also bested Trump in a Fox News survey among registered voters. Biden raked in 49 points against Trump’s 40 percent based on the results of Fox News’ survey, which was released last week.
Biden also led by 3 points in a polled conducted by Monmouth University. The results revealed that Biden got 48 percent against Trump’s 45 percent.
According to the publication, the results of the three polls show a consistent pattern. Donald Trump has improved his approval rating but it might not translate to a vote for his second term. “The polls suggest a slightly larger-than-usual slice of Democratic-leaning and independent voters are telling pollsters they now approve of the job Trump is doing as president — but support for giving him a second term lags behind among these same voters,” Politico wrote.
Trump’s approval rating reached a new high based on recent polls. The POTUS has an average approval rating of 47 percent, the highest since he became the President, NPR reported. The figure also represents a three-point increase over the last two weeks.
A Gallup poll revealed that 60 percent of American adults approve of how Trump is handling the coronavirus pandemic. Meanwhile, 51 percent of Fox News’ respondents approved of his handling of the health crisis. Meanwhile, both Reuters/Ipsos and Economist/YouGov polls revealed that 49 percent approved of his actions.
“No, I think that we've handled it really well,” Trump said on Monday. “The American public thinks that we've handled it well if you look at polling data.”
However, an expert said that the bounce to his popularity is minimal. “We're seeing although his numbers have inched up, it's still roughly in his zone of support,” Marist College Institute for Public Opinion director Lee Miringoff said. “Look, he's not getting the rally-around-the-president [effect] that presidents in crisis have gotten.”


Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
U.S.-Russia Talks Leave Ukraine Peace Efforts Uncertain
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Maduro Confirms “Respectful” Call With Trump, Signals Openness to Diplomatic Dialogue
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Trump Administration Halts Immigration, Green Card, and Citizenship Processing for 19 Countries
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Drones Spotted Near Zelenskiy’s Flight Path in Ireland Trigger Security Alert
China’s Expanding Maritime Military Presence Alarms Taiwan and Japan
U.S. Repatriation Flight Carrying 266 Venezuelan Migrants Lands in Caracas
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Honduras Election Turmoil Intensifies as Nasralla Blames Trump for Shift in Results
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 



